Goldman Sachs Downgrades Keurig Dr Pepper to Neutral, Lowers Price Target to $37
Goldman Sachs analyst Bonnie Herzog downgrades Keurig Dr Pepper (NASDAQ:KDP) from Buy to Neutral and lowers the price target from $39 to $37.
Is Uber Eating Lyft’s Lunch? Here’s What UBS Says About The Head-On Collision In Rideshare
UBS analysts see limited upside in shares of Lyft Inc (NASDAQ: LYFT) as the company faces structural headwinds relative to its competition.
SMBC Nikko Downgrades Paymentus Holdings to Neutral, Lowers Price Target to $13
SMBC Nikko analyst Andrew Bauch downgrades Paymentus Holdings (NYSE:PAY) from Outperform to Neutral and lowers the price target from $23 to $13.
UBS Downgrades Lyft to Neutral, Lowers Price Target to $16
UBS analyst Lloyd Walmsley downgrades Lyft (NASDAQ:LYFT) from Buy to Neutral and lowers the price target from $50 to $16.
Morgan Stanley Downgrades Core Laboratories to Underweight, Announces $20 Price Target
Morgan Stanley analyst Connor Lynagh downgrades Core Laboratories (NYSE:CLB) from Equal-Weight to Underweight and announces $20 price target.
UBS Downgrades Immunovant to Neutral, Lowers Price Target to $5
UBS analyst Colin Bristow downgrades Immunovant (NASDAQ:IMVT) from Buy to Neutral and lowers the price target from $7 to $5.
Jefferies Downgrades Safe Bulkers to Hold, Lowers Price Target to $4
Jefferies analyst Omar Nokta downgrades Safe Bulkers (NYSE:SB) from Buy to Hold and lowers the price target from $5 to $4.
Jefferies Downgrades Golden Ocean Group to Hold, Lowers Price Target to $10
Jefferies analyst Omar Nokta downgrades Golden Ocean Group (NASDAQ:GOGL) from Buy to Hold and lowers the price target from $14 to $10.
Jefferies Downgrades Diana Shipping to Hold, Lowers Price Target to $5
Jefferies analyst Omar Nokta downgrades Diana Shipping (NYSE:DSX) from Buy to Hold and lowers the price target from $7 to $5.
Keybanc Downgrades Sotera Health to Sector Weight
Keybanc analyst Matthew Mishan downgrades Sotera Health (NASDAQ:SHC) from Overweight to Sector Weight.